Connors Investor Services Inc. grew its holdings in shares of iRadimed Corporation (NASDAQ:IRMD) by 10.0% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 33,000 shares of the medical equipment provider’s stock after acquiring an additional 3,000 shares during the period. Connors Investor Services Inc. owned about 0.31% of iRadimed Corporation worth $284,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also modified their holdings of the company. Oxford Asset Management boosted its holdings in iRadimed Corporation by 85.4% in the 1st quarter. Oxford Asset Management now owns 65,663 shares of the medical equipment provider’s stock worth $584,000 after buying an additional 30,238 shares during the period. Neuberger Berman Group LLC bought a new position in iRadimed Corporation in the 1st quarter worth $134,000. Menta Capital LLC boosted its holdings in iRadimed Corporation by 25.0% in the 1st quarter. Menta Capital LLC now owns 66,653 shares of the medical equipment provider’s stock worth $593,000 after buying an additional 13,339 shares during the period. Globeflex Capital L P boosted its holdings in iRadimed Corporation by 92.0% in the 1st quarter. Globeflex Capital L P now owns 85,151 shares of the medical equipment provider’s stock worth $758,000 after buying an additional 40,800 shares during the period. Finally, AQR Capital Management LLC boosted its holdings in iRadimed Corporation by 25.9% in the 1st quarter. AQR Capital Management LLC now owns 137,663 shares of the medical equipment provider’s stock worth $1,225,000 after buying an additional 28,345 shares during the period. 14.19% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION NOTICE: “Connors Investor Services Inc. Acquires 3,000 Shares of iRadimed Corporation (IRMD)” was first posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another domain, it was illegally copied and reposted in violation of United States & international copyright & trademark law. The legal version of this story can be accessed at https://www.dailypolitical.com/2017/09/23/connors-investor-services-inc-acquires-3000-shares-of-iradimed-corporation-irmd.html.

iRadimed Corporation (IRMD) opened at 9.55 on Friday. The company has a 50-day moving average of $9.94 and a 200 day moving average of $8.89. The company has a market cap of $101.06 million, a P/E ratio of 39.96 and a beta of 1.50. iRadimed Corporation has a one year low of $7.85 and a one year high of $18.00.

iRadimed Corporation (NASDAQ:IRMD) last released its quarterly earnings results on Friday, July 28th. The medical equipment provider reported $0.06 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.01) by $0.07. The company had revenue of $5.50 million for the quarter, compared to analyst estimates of $5.41 million. iRadimed Corporation had a net margin of 11.61% and a return on equity of 8.98%. The firm’s revenue was down 44.4% on a year-over-year basis. During the same quarter last year, the business earned $0.24 earnings per share. Analysts anticipate that iRadimed Corporation will post $0.13 earnings per share for the current year.

Several research analysts recently weighed in on the stock. Zacks Investment Research raised shares of iRadimed Corporation from a “hold” rating to a “buy” rating and set a $11.00 target price for the company in a report on Friday, August 4th. Roth Capital raised shares of iRadimed Corporation from a “neutral” rating to a “buy” rating and upped their target price for the stock from $9.00 to $12.00 in a report on Monday, July 31st. TheStreet raised shares of iRadimed Corporation from a “d” rating to a “c-” rating in a report on Friday, June 23rd. Finally, ValuEngine downgraded shares of iRadimed Corporation from a “hold” rating to a “sell” rating in a report on Saturday, June 24th.

iRadimed Corporation Profile

IRADIMED CORPORATION (IRADIMED) develops, manufactures, markets and distributes Magnetic Resonance Imaging (MRI) compatible products, and provides non-magnetic intravenous (IV) infusion pump systems. The Company operates through development, manufacture and sale of MRI compatible products and IV infusion pump systems for use by hospitals and acute care facilities during MRI procedures segment.

Want to see what other hedge funds are holding IRMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for iRadimed Corporation (NASDAQ:IRMD).

Institutional Ownership by Quarter for iRadimed Corporation (NASDAQ:IRMD)

Receive News & Ratings for iRadimed Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iRadimed Corporation and related companies with MarketBeat.com's FREE daily email newsletter.